» Articles » PMID: 27772789

Neuropsychiatric Characteristics of GBA-associated Parkinson Disease

Abstract

Mutations in GBA1 are a well-established risk factor for Parkinson disease (PD). GBA-associated PD (GBA-PD) may have a higher burden of nonmotor symptoms than idiopathic PD (IPD). We sought to characterize the relationship between GBA-PD and neuropsychiatric symptoms. Subjects were screened for common GBA1 mutations. GBA-PD (n=31) and non-carrier (IPD; n=55) scores were compared on the Unified Parkinson Disease Rating Scale (UPDRS), Montreal Cognitive Assessment (MoCA), Beck Depression Inventory (BDI), and the State-Trait Anxiety Index (STAI). In univariate comparisons, GBA-PD had a greater prevalence of depression (33.3%) versus IPD (13.2%) (p<0.05). In regression models controlling for age, sex, disease duration, motor disability, and MoCA score, GBA-PD had an increased odds of depression (OR 3.66, 95% CI 1.13-11.8) (p=0.03). Post-hoc analysis stratified by sex showed that, among men, GBA-PD had a higher burden of trait anxiety and depression than IPD; this finding was sustained in multivariate models. Among women, GBA-PD did not confer greater psychiatric morbidity than IPD. These results suggest that GBA1 mutations confer greater risk of neuropsychiatric morbidity in PD, and that sex may affect this association.

Citing Articles

A Global Perspective of -Related Parkinson's Disease: A Narrative Review.

Koros C, Bougea A, Alefanti I, Simitsi A, Papagiannakis N, Pachi I Genes (Basel). 2025; 15(12.

PMID: 39766872 PMC: 11675599. DOI: 10.3390/genes15121605.


Are patients with GBA-Parkinson disease good candidates for deep brain stimulation? A longitudinal multicentric study on a large Italian cohort.

Avenali M, Zangaglia R, Cuconato G, Palmieri I, Albanese A, Artusi C J Neurol Neurosurg Psychiatry. 2023; 95(4):309-315.

PMID: 37879897 PMC: 10958298. DOI: 10.1136/jnnp-2023-332387.


Dysphagia in Parkinson Disease: Part I - Pathophysiology and Diagnostic Practices.

Rudisch D, Krasko M, Burdick R, Broadfoot C, Rogus-Pulia N, Ciucci M Curr Phys Med Rehabil Rep. 2023; 11(2):176-187.

PMID: 37608845 PMC: 10441627. DOI: 10.1007/s40141-023-00392-9.


GBA1 Variants and Parkinson's Disease: Paving the Way for Targeted Therapy.

Huh Y, Usnich T, Scherzer C, Klein C, Chung S J Mov Disord. 2023; 16(3):261-278.

PMID: 37302978 PMC: 10548077. DOI: 10.14802/jmd.23023.


The Influence of GBA and LRRK2 on Mood Disorders in Parkinson's Disease.

Debroff J, Omer N, Cohen B, Giladi N, Kestenbaum M, Shirvan J Mov Disord Clin Pract. 2023; 10(4):606-616.

PMID: 37070047 PMC: 10105114. DOI: 10.1002/mdc3.13722.


References
1.
Becker C, Brobert G, Johansson S, Jick S, Meier C . Risk of incident depression in patients with Parkinson disease in the UK. Eur J Neurol. 2010; 18(3):448-53. DOI: 10.1111/j.1468-1331.2010.03176.x. View

2.
Alcalay R, Caccappolo E, Mejia-Santana H, Tang M, Rosado L, Orbe Reilly M . Cognitive performance of GBA mutation carriers with early-onset PD: the CORE-PD study. Neurology. 2012; 78(18):1434-40. PMC: 3345785. DOI: 10.1212/WNL.0b013e318253d54b. View

3.
Stefanova E, Ziropadja L, Petrovic M, Stojkovic T, Kostic V . Screening for anxiety symptoms in Parkinson disease: a cross-sectional study. J Geriatr Psychiatry Neurol. 2013; 26(1):34-40. DOI: 10.1177/0891988713476368. View

4.
Walter U, Skoloudik D, Berg D . Transcranial sonography findings related to non-motor features of Parkinson's disease. J Neurol Sci. 2009; 289(1-2):123-7. DOI: 10.1016/j.jns.2009.08.027. View

5.
Shulman L, Taback R, BEAN J, Weiner W . Comorbidity of the nonmotor symptoms of Parkinson's disease. Mov Disord. 2001; 16(3):507-10. DOI: 10.1002/mds.1099. View